Showing 6621-6630 of 20916 results for "".
- The Looming Global Crisis: Overweight and Obesity Trends Towards 2050https://reachmd.com/news/the-looming-global-crisis-overweight-and-obesity-trends-towards-2050/2471458/A Forecast Reveals Over Half of Adults and One Third of Youth May Face Obesity by 2050 According to a recent analysis by the Global Burden of Disease Study BMI Collaborators published in The Lancet, projections indicate that more than half of th
- Revolutionizing Stroke Diagnosis: The Promise of Light and Sound Technologyhttps://reachmd.com/news/revolutionizing-stroke-diagnosis-the-promise-of-light-and-sound-technology/2471527/Unlocking Real-Time Stroke Insights for Rapid Intervention Breakthrough research by the POSTECH team unveils a novel technology that uses a combination of light and sound to monitor vascular changes in the brain, promising timelier stroke diagnosis and impro
- Advancing Pediatric Emergency Triage: A Machine Learning Perspectivehttps://reachmd.com/news/advancing-pediatric-emergency-triage-a-machine-learning-perspective/2471575/Harnessing Machine Learning to Revolutionize Pediatric Emergency Triage This article examines how integrating machine learning techniques into pediatric emergency triage can significantly enhance prediction accuracy. By comparing traditional method
- Advanced MRI Reveals Hidden Lung Changes in Young Long COVID Patientshttps://reachmd.com/news/advanced-mri-reveals-hidden-lung-changes-in-young-long-covid-patients/2471455/Uncovering the Invisible: Advanced MRI Exposes Critical Lung Changes in Pediatric Long COVID Recent investigations have highlighted the potential of advanced MRI techniques, such as Phase-Resolved Functional Lung MRI (PREFUL MRI), to detect subtle lung abnormalitie
- Exploring Socioeconomic Determinants in Pediatric COVID-19 Vaccine Hesitancyhttps://reachmd.com/news/exploring-socioeconomic-determinants-in-pediatric-covid-19-vaccine-hesitancy/2471561/Recent observations in the San Francisco Bay Area indicate that low parental income levels are associated with increased vaccine hesitancy among the pediatric population, highlighting significant socioeconomic barriers to COVID-19 vaccination.
- Exploring Gene Therapy and Genome-Editing Approaches for NF2-Related Schwannomatosishttps://reachmd.com/news/exploring-gene-therapy-and-genome-editing-approaches-for-nf2-related-schwannomatosis/2471562/Recent advancements in gene therapy and genome-editing have ushered in a new era in the treatment of NF2-related schwannomatosis, offering promising avenues for tumor regression and personalized interventions. Researchers are now harnessing advanced techniques like gene the
- Revolutionizing Cardiac Care: The Living Mitral Valve Transplant Breakthroughhttps://reachmd.com/news/revolutionizing-cardiac-care-the-living-mitral-valve-transplant-breakthrough/2471465/Duke Health has performed the world’s first living mitral valve transplant, a pioneering procedure in pediatric cardiac surgery. The operation, which involved transplanting healthy valves from a full-heart transplant recipient to two other children, cou
- Overcoming Barriers: Ensuring the Sustainability of SNAP-Ed Programs in Schoolshttps://reachmd.com/news/overcoming-barriers-ensuring-the-sustainability-of-snap-ed-programs-in-schools/2471464/Addressing Administrative and Funding Challenges to Empower Nutrition Education SNAP-Ed programs in schools face significant obstacles that threaten the continuity of essential nutrition education initiatives. This article highlights strategic partnerships and inte
- Biologics, JAKs, and More Cited as Potential Treatments for CPUOhttps://reachmd.com/news/Biologics-JAKis-More-Cited-Potential-Treatments-CPUO/2471552/New therapies for chronic pruritus of unknown origin (CPUO) could be close, Gil Yosipovitch, MD, said during his presentation, “What’s Best and What’s Next for Systemic Itch and CPUO” at the 2025 American Academy of Dermatology (AAD) Annual Meeting in Orlando, Florida. “These are patients
- FDA Approves South Korean Neurotoxin for Frown Lineshttps://reachmd.com/news/fda-approves-south-korean-neurotoxin-for-frown-lines/2473751/The US Food and Drug Administration approved the neurotoxin, Letybo (letibotulinumtoxinA-wlbg), to treat moderate-to-severe glabellar lines in adults, Hugel Inc. announced last week. According to a press release, Hugel Inc. plans to accelerate its transition for approved medical use with